Large-scale testing (Phase 3)Study completedNCT01485614
What this trial is testing
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Who this might be right for
Diabetes MellitusType 2 Diabetes
Merck Sharp & Dohme LLC 200